Pseudo-G-Rh2 induces mitochondrial-mediated apoptosis in SGC-7901 human gastric cancer cells

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1441-1446

  Qu, Xiangru ^a   Qu, Shaochun ^a   Yu, Xiaofeng ^a   Xu, Huali ^a   Chen, Yanping ^a   Ma, Xingyuan ^a   Sui, Dayuan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase; Mitochondrial membrane potential; Pseudo ginsenoside Rh2; SGC 7901

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; PSUEDO GINSENOSIDE RH 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOCHROMES C; GINSENOSIDES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; STOMACH NEOPLASMS;

EID: 80053495327     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1442     Document Type: Article

References (25)

1. Zhang W, Ha M, Gong Y, Xu Y, Dong N and Yuan Y: Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways. Oncol Rep 24: 1585-1592, 2010.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
3. Colozza M, De Azambuja E, Personeni N, Lebrun F, Piccart MJ and Cardoso F: Achievements in systemic therapies in the pregenomic era in metastatic breast cancer. Oncologist 12: 253-270, 2007. (Pubitemid 46556792)
4. Kopetz S, Chang GJ, Overman MJ, et al: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27: 3677-3683, 2009.
5. Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55: 178-194, 2005. (Pubitemid 40826487)
6. Kiefer D and Pantuso T: Panax ginseng. Am Fam Physician 68: 1539-1542, 2003. (Pubitemid 37296048)
7. Oh M, Choi YH, Choi S, et al: Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 14: 869-875, 1999.
8. Lee KY, Park JA, Chung E, Lee YH, Kim SI and Lee SK: Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett 110: 193-200, 1996. (Pubitemid 27042941)
9. Kim HE, Oh JH, Lee SK and Oh YJ: Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway. Life Sci 65: 33-40, 1999.
10. Kim YS, Jin SH, Lee YH, Park JD and Kim SI: Differential expression of protein kinase C subtypes during ginsenoside Rh2-Induced apoptosis in SK-N-BE(2) and C6Bu-1 cells. Arch Pharm Res 23: 518-524, 2000.
11. Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS and Ikejima T: Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin 23: 315-322, 2002. (Pubitemid 34266588)
12. Hasegawa H, Sung JH, Matsumiya S and Uchiyama M: Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 62: 453-457, 1996. (Pubitemid 26370341)
13. Lee SJ, Sung JH, Lee SJ, Moon CK and Lee BH: Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 144: 39-43, 1999.
14. Atopkina LN, Malinovskaya GV, Elyakov GB, et al: Cytotoxicity of natural ginseng glycosides and semisynthetic analogues. Planta Med 65: 30-34, 1999. (Pubitemid 29077424)
15. Porn-Ares MI, Chow SC, Slotte JP and Orrenius S: Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609. Exp Cell Res 235: 48-54, 1997. (Pubitemid 27381680)
16. Alberts SR, Cervantes A and Van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14 (Suppl 2): 31-36, 2003.
17. Tahara E: Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol 84: 43-49, 2000.
18. Vaux DL and Korsmeyer SJ: Cell death in development. Cell 96: 245-254, 1999. (Pubitemid 29059354)
19. Desagher S and Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol 10: 369-377, 2000. (Pubitemid 30612469)
20. Reed JC: Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 7: 314-319, 2001.
21. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X and Akey CW: Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9: 423-432, 2002. (Pubitemid 34195566)
22. Du C, Fang M, Li Y, Li L and Wang X: Smac/Diablo, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
23. Joza N, Susin SA, Daugas E, et al: Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554, 2001. (Pubitemid 32267191)
24. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
25. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999. (Pubitemid 32250377)